Targeted polysaccharide nanoparticle for adamplatin prodrug delivery

Journal of Medicinal Chemistry

Volumn 56, Issue 23, 2013, Pages 9725-9736

  Yang, Yang ^a   Zhang, Ying Ming ^a   Chen, Yong ^a   Chen, Jia Tong ^b   Liu, Yu ^a  

^a Tianjin Engineering Center of Micro Nano Biomaterials and Detection Treatment Technology   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMPLATIN; ANTINEOPLASTIC AGENT; CISPLATIN; NANOPARTICLE; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGHT SCATTERING; NEOPLASM; PROTON NUCLEAR MAGNETIC RESONANCE; ZETA POTENTIAL;

EID: 84890473363     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4014168     Document Type: Article

References (64)

1. Caldorera-Moore, M. E.; Liechty, W. B.; Peppas, N. Responsive theranostic systems: Integration of diagnostic imaging agents and responsive controlled release drug delivery carriers Acc. Chem. Res. 2011, 44, 1061-1070
2. Mintzer, M. A.; Simanek, E. E. Nonviral vectors for gene delivery Chem. Rev. 2009, 109, 259-302
3. Lee, S.; Chen, H.; O'Halloran, T. V.; Nguyen, S. T. Clickable polymer-caged nanobins as a modular drug delivery platform J. Am. Chem. Soc. 2009, 131, 9311-9320
4. Al-Jamal, W. T.; Kostarelos, K. Liposomes: From a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine Acc. Chem. Res. 2011, 44, 1094-1104
5. Landmark, K. J.; DiMaggio, S.; Ward, J.; Kelly, C.; Vogt, S.; Hong, S.; Kotlyar, A.; Myc, A.; Thomas, T. P.; Penner-Hahn, J. E.; Baker, J. R., Jr.; Holl, M. M. B.; Orr, B. J. Synthesis, characterization, and in vitro testing of superparamagnetic iron oxide nanoparticles targeted using folic acid-conjugated dendrimers ACS Nano 2008, 2, 773-783
6. Hayashi, K.; Ono, K.; Suzuki, H.; Sawada, M.; Moriya, M.; Sakamoto, W.; Yogo, T. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect ACS Appl. Mater. Interfaces 2010, 2, 1903-1911
7. Ambrogio, M. W.; Thomas, C. R.; Zhao, Y.; Zink, J. I.; Stoddart, J. F. Mechanized silica nanoparticles: A new frontier in theranostic nanomedicine Acc. Chem. Res. 2011, 44, 903-913
8. Vallet-Regi, M.; Colilla, M.; Gonzalez, B. Medical applications of organic-inorganic hybrid materials within the field of silica-based bioceramics Chem. Soc. Rev. 2011, 40, 596-607
9. Du, J.; Sun, T.; Song, W.; Wu, J.; Wang, J. A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery Angew. Chem., Int. Ed. 2010, 49, 3621-3626
10. Soppimath, K. S.; Liu, L.-H.; Seow, W. Y.; Liu, S.-Q.; Powell, R.; Chan, P.; Yang, Y. Y. Multifunctional core/shell nanoparticles self-assembled from pH-induced thermosensitive polymers for targeted intracellular anticancer drug delivery Adv. Funct. Mater. 2007, 17, 355-362
11. Dam, H. H.; Caruso, F. Construction and degradation of polyrotaxane multilayers Adv. Mater. 2011, 23, 3026-3029
12. Tanner, P.; Baumann, P.; Enea, R.; Onaca, O.; Palivan, C.; Meier, W. Polymeric vesicles: From drug carriers to nanoreactors and artificial organelles Acc. Chem. Res. 2011, 44, 1039-1049
13. Kim, E.; Kim, D.; Jung, H.; Lee, J.; Paul, S.; Selvapalam, N.; Yang, Y.; Lim, N.; Park, C. G.; Kim, K. Facile, template-free synthesis of stimuli-responsive polymer nanocapsules for targeted drug delivery Angew. Chem., Int. Ed. 2010, 49, 4405-4408
14. Liu, Z.; Sun, X.; Nakayama-Ratchford, N.; Dai, H. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery ACS Nano 2007, 1, 50-56
15. Liu, Z.; Robinson, J. T.; Sun, X.; Dai, H. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs J. Am. Chem. Soc. 2008, 130, 10876-10877
16. Dhar, S.; Liu, Z.; Thomale, J.; Dai, H.; Lippard, S. J. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device J. Am. Chem. Soc. 2008, 130, 11467-11476
17. Sun, X.; Liu, Z.; Welsher, K.; Robinson, J. T.; Goodwin, A.; Zaric, S.; Dai, H. Nano-graphene oxide for cellular imaging and drug delivery Nano Res. 2008, 1, 203-212
18. Zhang, L.; Xia, J.; Zhao, Q.; Liu, L.; Zhang, Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs Small 2010, 6, 537-544
19. Yang, Y.; Zhang, Y.-M.; Chen, Y.; Zhao, D.; Chen, J.-T.; Liu, Y. Construction of a graphene oxide based noncovalent multiple nanosupramolecular assembly as a scaffold for drug delivery Chem.-Eur. J. 2012, 18, 4208-4215
20. Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery Nano Res. 2009, 2, 85-120
21. Ghaderi, S.; Ramesh, B.; Seifalian, A. M. Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity J. Drug Targeting 2011, 19, 475-486
22. Kreuter, J. Evaluation of nanoparticles as drug-delivery systems, III: Materials, stability, toxicity, possibilities of targeting, and use Pharm. Acta Helv. 1983, 58, 242-250
23. Mizrahy, S.; Peer, D. Polysaccharide as building blocks for nanotherapeutics Chem. Soc. Rev. 2012, 41, 2623-2640
24. Sung, H.-W.; Sonaje, K.; Liao, Z.-X.; Hsu, L.-W.; Chuang, E.-Y. pH-Responsive nanoparticles shelled with chitosan for oral delivery of insulin: From mechanism to therapeutic applications Acc. Chem. Res. 2012, 45, 619-629
25. Seeberger, P. H.; Werz, D. B. Synthesis and medical applications of oligosaccharides Nature 2007, 446, 1046-1051
26. Langer, R. New methods of drug delivery Science 1990, 249, 1527-1533
27. Seliktar, D. Designing cell-compatible hydrogels for biomedical applications Science 2012, 336, 1124-1128
28. Peer, D.; Margalit, R. Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models Int. J. Cancer 2004, 108, 780-789
29. Rivkin, I.; Cohen, K.; Koffler, J.; Melikhov, D.; Peer, D.; Margalit, R. Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors Biomaterials 2010, 31, 7106-7114
30. Bachar, G.; Cohen, K.; Hod, R.; Feinmesser, R.; Mizrachi, A.; Shpitzer, T.; Katz, O.; Peer, D. Hyaluronan-grafted particle clusters loaded with mitomycin C as selective nanovectors for primary head and neck cancers Biomaterials 2011, 32, 4840-4848
31. Park, K. M.; Yang, J.-A.; Jung, H.; Yeom, J.; Park, J. S.; Park, K.-H.; Hoffman, A. S.; Hahn, S. K.; Kim, K. In situ supramolecular assembly and modular modification of hyaluronic acid hydrogels for 3D cellular engineering ACS Nano 2012, 6, 2960-2968
32. Han, S.-Y.; Han, H. S.; Lee, S. C.; Kang, Y. M.; Kim, I.-S.; Park, J. H. Mineralized hyaluronic acid nanoparticles as a robust drug carrier J. Mater. Chem. 2011, 21, 7996-8001
33. Luo, Y.; Prestwich, G. D. Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate Bioconjugate Chem. 1999, 10, 755-763
34. Luo, Y.; Ziebell, M. R.; Prestwich, G. D. A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells Biomacromolecules 2000, 1, 208-218
35. Lee, H.; Lee, K.; Park, T. G. Hyaluronic acid-paclitaxel conjugate micelles: Synthesis, characterization, and antitumor activity Bioconjugate Chem. 2008, 19, 1319-1325
36. Lee, M.-Y.; Park, S.-J.; Park, K.; Kim, K. S.; Lee, H.; Hahn, S. K. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/ siRNA/PEI/HA nanocomplex ACS Nano 2011, 5, 6138-6147
37. Choi, K. Y.; Min, K. H.; Na, J. H.; Choi, K.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: Synthesis, characterization, and in vivo biodistribution J. Mater. Chem. 2009, 19, 4102-4107
38. Choi, K. Y.; Chung, H.; Min, K. H.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Jeong, S. Y. Self-assembled hyaluronic acid nanoparticles for active tumor targeting Biomaterials 2010, 31, 106-114
39. Choi, K. Y.; Min, K. H.; Yoon, H. Y.; Kim, K.; Park, J. H.; Kwon, I. C.; Choi, K.; Jeong, S. Y. PEGylation of hyaluronic acid nanopartilces improves tumor targetability in vivo Biomaterials 2011, 32, 1880-1889
40. Choi, K. Y.; Yoon, H. Y.; Kim, J.-H.; Bae, S. M.; Park, R.-W.; Kang, Y. M.; Kim, I.-S.; Kwon, I. C.; Choi, K.; Jeong, S. Y.; Kim, K.; Park, J. H. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy ACS Nano 2011, 5, 8591-8599
41. Peer, D.; Park, E. J.; Morishita, Y.; Carman, C. V.; Shimaoka, M. Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target Science 2008, 319, 627-630
42. Peer, D.; Zhu, P.; Carman, C. V.; Lieberman, J.; Shimaoka, M. Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1 Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 4095-4100
43. Liu, G.; Choi, K. Y.; Bhirde, A.; Swierczewska, M.; Yin, J.; Lee, S. W.; Park, J. H.; Hong, J. I.; Xie, J.; Niu, G.; Kiesewetter, D. O.; Lee, S.; Chen, X. Sticky nanoparticles: A platform for siRNA delivery by a bis(zinc(II) dipicolylamine)-functionalized, self-assembled nanoconjugate Angew. Chem., Int. Ed. 2012, 51, 445-449
44. Chen, Y.; Liu, Y. Cyclodextrin-based bioactive supramolecular assemblies Chem. Soc. Rev. 2010, 39, 495-505
45. Chen, Y.; Zhang, Y.-M.; Liu, Y. Multidimensional nanoarchitectures based on cyclodextrins Chem. Commun. 2010, 46, 5622-5633
46. Yokoyama, M.; Okano, T.; Sakurai, Y.; Suwa, S.; Kataoka, K. Introduction of cisplatin into polymeric micelle J. Controlled Release 1996, 39, 351-356
47. Eftink, M. R.; Andy, M. L.; Bystrom, K.; Perlmutter, H. D.; Kristol, D. S. Cyclodextrin inclusion complexes: Studies of the variation in the size of alicyclic guests J. Am. Chem. Soc. 1989, 111, 6765-6772
48. Toole, B. P. Hyaluronan: From extracellular glue to pericellular cue Nat. Rev. Cancer 2004, 4, 528-539
49. Bertrand, P.; Girard, N.; Duval, C.; d'Anjou, J.; Chauzy, C.; Menard, J.-F.; Delpech, B. Increased hyaluronidase levels in breast tumor metastases Int. J. Cancer 1997, 73, 327-331
50. Lokeshwar, V. B.; Lokeshwar, B. L.; Pham, H. T.; Block, N. L. Association of elevated levels of hyaluronidase, a matrix-degrading enzyme, with prostate cancer progression Cancer Res. 1996, 56, 651-657
51. Stern, R. Hyaluronidase in cancer biology Semin. Cancer Biol. 2008, 18, 275-280
52. Jaracz, S.; Chen, J.; Kuznetsova, L. V.; Ojima, I. Recent advances in tumor-targeting anticancer drug conjugates Bioorg. Med. Chem. 2005, 13, 5043-5054
53. IV complexes of amantadine and their antitumor activity against L-1210 in BDF/2 Nanjing Daxue Xuebao, Ziran Kexue 1984, 471-478
54. Kasparkova, J.; Novakova, O.; Vrana, O.; Intini, F.; Natile, G.; Brabec, V. Molecular aspects of antitumor effects of a new platinum (VI) drug Mol. Pharmacol. 2006, 70, 1708-1719
55. 2. A high performance liquid chromatographic application of kurnakow's test Polyhedron 1983, 2, 175-178
56. 2+ sensors Bioorg. Med. Chem. 2010, 18, 1415-1420
57. Nitta, K.; Miyake, J.; Watanabe, J.; Ikeda, Y. Gel formation driven by tunable hydrophobic domain: Design of acrylamide macromonomer with oligo hydrophobic segment Biomacromolecules 2012, 13, 1002-1009
58. Needham, C. J.; Williams, A. K.; Chew, S. A.; Kasper, F. K.; Mikos, A. G. Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid Biomacromolecules 2012, 13, 1429-1437
59. Lee, H.; Mok, H.; Lee, S.; Oh, Y. K.; Park, T. G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels J. Controlled Release 2007, 119, 245-252
60. Caron, G.; Ermondi, G.; Gariboldi, M. B.; Monti, E.; Gabano, E.; Ravera, M.; Osella, D. The relevance of polar surface area (PSA) in rationalizing biological properties of several cis -diamminemalonatoplatinum (II) derivatives ChemMedChem 2009, 4, 1677-1685
61. Luo, Y.; Bernshaw, N. J.; Lu, Z.; Lopecek, J.; Prestwich, G. D. Targeted delivery of doxorubicin by HPMA copolymer-hyaluronan bioconjugates Pharm. Res. 2002, 19, 396-402
62. Xiao, H.; Song, H.; Zhang, Y.; Qi, R.; Wang, R.; Xie, Z.; Huang, Y.; Li, Y.; Wu, Y.; Jing, X. The use of polymeric platinum(IV) prodrugs to deliver multinuclear platinum(II) drugs with reduced systemic toxicity and enhanced antitumor efficacy Biomaterials 2012, 33, 8657-8669
63. A-polyamine-mono-substituted β -cyclodextrins J. Chem. Soc., Perkin Trans. 1 1997, 3157-3160
64. Gentsch, R.; Pippig, F.; Nilles, K.; Theato, P.; Kikkeri, R.; Maglinao, M.; Lepenies, B.; Seeberger, P. H.; Borner, H. G. Modular approach toward bioactive fiber meshes carrying oligosaccharides Macromolecules 2010, 43, 9239-9247